Search clinical trials for: Empagliflozin (Jardiance®;
Total 14687 results
-
Dong-A ST Co., Ltd.CompletedType2 DiabetesKorea, Republic of
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
October 6 UniversityUniversity of Florida; Beni-Suef University; National Heart Institute, EgyptRecruitingHeart Failure | Genetic PolymorphismsUnited States
-
Damanhour UniversityRecruitingHeart Failure | Reduced Ejection Fraction Heart FailureEgypt
-
Clinical Research Centre, MalaysiaUniversity of Malaya; Ministry of Health, MalaysiaRecruitingCoronary Artery DiseaseMalaysia
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownType 2 Diabetes MellitusMexico
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of... and other collaboratorsRecruitingAcute Decompensated Heart FailurePoland
-
Boehringer IngelheimRecruitingHeart FailureKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
University of PennsylvaniaRecruitingHeart Failure With Preserved Ejection FractionUnited States
-
University Hospital TuebingenWithdrawn
-
Pharma NuevaNot yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Australia, Greece, Italy, Norway, Poland, Portugal, Sweden
-
China National Center for Cardiovascular DiseasesRecruitingHypertension | Pre-Heart FailureChina
-
Ministry of Health and Population, EgyptCompleted
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimRecruitingPostprandial HypoglycemiaSwitzerland
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
LG ChemUnknown
-
Ain Shams UniversityDrug Research Centre, Cairo, EgyptCompletedDiabetes Mellitus | Pharmacokinetics | PharmacodynamicsEgypt
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial HospitalNot yet recruitingHeart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
Boehringer IngelheimActive, not recruitingHeart FailureCzechia, Switzerland, Poland, Hungary, Romania, Bulgaria
-
Boehringer IngelheimCompleted
-
Seoul National University Bundang HospitalNot yet recruitingType 2 Diabetes | Metabolic-associated Fatty Liver Disease
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
University of Mississippi Medical CenterEli Lilly and CompanyRecruiting
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
Vanderbilt University Medical CenterRecruitingObesity | Metabolic SyndromeUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Boehringer...Recruiting
-
Washington University School of MedicineRecruitingEpilepsyUnited States
-
University of UtahNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHemodialysis | Kidney Disease, Chronic | Kidney Failure | Dialysis | Diabetic | End-stage Kidney Disease | Kidney Dysfunction | Non-diabeticUnited States
-
Maria Sklodowska-Curie National Research Institute...Medical Research Agency, PolandRecruiting
-
National Institute of Cardiology, Warsaw, PolandAmsterdam UMC, location VUmc; University of Eastern Finland; Medical University...RecruitingHeart Failure | Hypertrophic CardiomyopathyPoland